Cognetivity Neurosciences Ltd. (1UB.F)

0.0025 0.0000 (0.00%) As of 08:16AM CEST. Market open.

Cognetivity Neurosciences Ltd.

1055 West Hastings Street
Suite 2250
Vancouver, BC V6E 2E9
Canada

https://cognetivity.com

Sector(s): Healthcare
Industry: Health Information Services
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Sina Habibi	Co-Founder, CEO & Director	990.57k	N/A	N/A
Dr. Seyed-Mahdi Khaligh-Razavi	Co-Founder & CIO	770.34k	N/A	N/A
Dr. Thomas Roger Sawyer M.B.A., Ph.D.	CFO, Company Secretary & Director	788.41k	N/A	1970
Mr. Desmond M. Balakrishnan B.A., L.L.B.	Legal Counsel & Director	N/A	N/A	1971

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Corporate Governance

Cognetivity Neurosciences Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.